Last reviewed · How we verify
Paroxysmal atrial fibrillation
Approved treatments
- Multaq · Sanofi
Multaq works by blocking abnormal electrical signals in the heart to restore a normal heartbeat. - Tambocor
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Paroxysmal atrial fibrillation patent landscape — cliff calendar, originator estates, attackable patents
- Paroxysmal atrial fibrillation treatment landscape brief
- Paroxysmal atrial fibrillation treatment updates RSS
Frequently asked questions about Paroxysmal atrial fibrillation
What drugs treat Paroxysmal atrial fibrillation?
Tracked treatments include Multaq, Tambocor.
What is the treatment for Paroxysmal atrial fibrillation?
Standard treatment for Paroxysmal atrial fibrillation includes Multaq, Tambocor. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Paroxysmal atrial fibrillation patent cliff · Paroxysmal atrial fibrillation CI report
- Treatment: Multaq · Sanofi
- Treatment: Tambocor
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing